ag亚游官网

  • <tr id='3Z5w7W'><strong id='3Z5w7W'></strong><small id='3Z5w7W'></small><button id='3Z5w7W'></button><li id='3Z5w7W'><noscript id='3Z5w7W'><big id='3Z5w7W'></big><dt id='3Z5w7W'></dt></noscript></li></tr><ol id='3Z5w7W'><option id='3Z5w7W'><table id='3Z5w7W'><blockquote id='3Z5w7W'><tbody id='3Z5w7W'></tbody></blockquote></table></option></ol><u id='3Z5w7W'></u><kbd id='3Z5w7W'><kbd id='3Z5w7W'></kbd></kbd>

    <code id='3Z5w7W'><strong id='3Z5w7W'></strong></code>

    <fieldset id='3Z5w7W'></fieldset>
          <span id='3Z5w7W'></span>

              <ins id='3Z5w7W'></ins>
              <acronym id='3Z5w7W'><em id='3Z5w7W'></em><td id='3Z5w7W'><div id='3Z5w7W'></div></td></acronym><address id='3Z5w7W'><big id='3Z5w7W'><big id='3Z5w7W'></big><legend id='3Z5w7W'></legend></big></address>

              <i id='3Z5w7W'><div id='3Z5w7W'><ins id='3Z5w7W'></ins></div></i>
              <i id='3Z5w7W'></i>
            1. <dl id='3Z5w7W'></dl>
              1. <blockquote id='3Z5w7W'><q id='3Z5w7W'><noscript id='3Z5w7W'></noscript><dt id='3Z5w7W'></dt></q></blockquote><noframes id='3Z5w7W'><i id='3Z5w7W'></i>

                中文

                公司新闻

                当前位置: 首页 > 新闻动态 > 公司新闻

                ag亚游手机客户端医疗任命Matthias Straub博士为首席医学官

                2020-06-15


                Link Health Appoints Chief Medical Officer


                Guangzhou, China; 15 June 2020 - Link Health Pharma Co., Ltd. (“Link Health”) announced today it has appointed Dr. Matthias Straub as Chief Medical Officer.


                Matthias Straub, MD, PhD, is a recognized pharmaceutical industry  leader and multidisciplinary expert. He has more than 29 years of experience in Clinical Development at big pharma companies such as Ciba Geigy, Solvay Pharmaceuticals, and Abbott Established Pharmaceuticals.


                As head of Global Clinical Developmet at major pharma companies, Dr. Straub has built and guided various clinical development departments with a track record in the design and conduct of clinical studies in all development phases and various therapeutic areas. For over 14 years he was responsible  for the final review of all clinical output regarding clinical development of the companies he served. He acted hands on as the responsible Global Clinical Director and Clinical Development Expert, including FDA Advisory Panel meetings, EMA, MHRA, and NMPA hearings for product approvals.


                Dr. Straub is a Registered Physician in Germany and has received a Doctors degree in Ophthalmology. He has published on various areas such as congestive heart failure, arrhythmias, and angina pectoris. He holds various patents primarily in the cardiovascular field and was part of the EFPIA efficacy working party for Solvay Pharmaceuticals.


                “Dr. Straub is a veterian in our industry. We are very pleased to have him on board to boost the clinical development of our pipeline. His extensive clinical development leadership experience and his hands on approach will definitely benefit us in establishing a world class medical organisation.” Said Yan Song, CEO of Link Health.


                About Link Health


                Link Health is a biopharmaceutical company developing innovative medicine for unmet medical needs. It has a drug development pipeline of 5 clinical stage assets and 1 under NDA reviewing in China. Headquartered in China, Link Health has an European office in the Netherlands to further strengthen the collaborations with global biopharmaceutical 


                2020年06月15日,广州。ag亚游手机客户端医疗科技有限公司正式任命Matthias Straub博士为公司首席医学官。Straub博士将全面参与ag亚游手机客户端在研的多个创新靶点的临床POC研究,支持领晟的国际合作以及海外申报,同时,Straub博士也将支持ag亚游手机客户端自主开发的骨科DMOAD药物为主的“骨新生”板块,计划年内申报美国FDA并计划同步开展II期临床研究。


                Matthias Straub(MD,PhD)是医药界公认的意见领袖和多学科专家,作为一位的资深行业领导者,Matthias Straub博士在临床开发领域拥有超过29年工作经验,先后任职Ciba Geigy,苏威制药和雅培等跨国企业。

                 

                Straub博士作为全球临床开发负责人,多次指导临床开发各阶段和众多治疗领域的临床研究设计和开展并获得成功,在过去的14年中,他对所服务公司的临床发展进行了临床结果的最终审查,并亲自担任临床总监、临床开发█专家参与到FDA咨询小组会议、EMA、MHRA、NMPA听证会,直至产品获得批准。

                 

                Straub博士是德国的注册医师,获得眼科博士学位,他在充血性心力衰竭、心律不齐和心绞痛等疾病领域曾发表文章,在心血管领域拥有多项专利,并曾作为苏威制药EFPIA(欧盟制药工业联合研发委员会)工作组成员,致力于研究、开发和生产新的医疗方法。

                 

                ag亚游手机客户端医疗CEO宋燕博士表示:“Straub博士是行业的资深人士,我们很高兴能邀请他加入我们,一起推动ag亚游手机客户端临床研发管线,他丰富的临床开发领导经验和实践经验,必将使我们在成为世界一流医药企业的路上收益匪浅。”

                 

                关于ag亚游手机客户端

                ag亚游手机客户端医疗是一家生物制药公司,致力于开发国内未满足的临床需求的创新药物。它在中国的研发管线包括了5个临床阶段的创新药和1个正在接受NDA审查的药物。ag亚游手机客户端医疗总部位于中国,并在荷兰设有欧洲办事处,以便公司加强与全球生物制药公司和研究机构的进一步合作。

                 

                合作联系

                更多项目信息或公司信息,请联系:

                王华   博士

                h.wang@healthinlink.com